A new visit to the center's opening: a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
A new visit to the center's opening: a clinical trial to study the efficacy and safety of tosorakimab, compared with placebo, in adult participants with symptomatic COPD in the presence of exacerbations with increased eosinophil levels.
